Teradyne Holds Steadier Than Peers Into Its Print

TER has outperformed its closest semiconductor equipment peers over the past week, falling 3.8% against a median decline of roughly 7% to 13% across correlated names. LRCX dropped 12.7%, COHU lost 9.3%, and FORM fell 8.2% over the same period. Teradyne's relative resilience is notable given its $323.68 close and the 19% monthly drawdown the stock has already absorbed.

Short positioning has eased into the report day, though it remains moderate. Short interest trimmed 5.4% in a single session on October 26, dropping to 4.9% of free float at roughly 7.7 million shares. That reverses some of the build seen over October. Earlier notes flagged a steady climb from around 7.3 million shares in mid-September to above 8.2 million, so the latest retreat marks a genuine shift. Borrow conditions stay loose: availability is at 7,228%, meaning shares to borrow vastly outnumber those already lent out, and cost to borrow is 0.49%, despite rising about 10% on the week. There is no squeeze pressure here.

Options tell a more cautious story, though the peak alarm has passed. The put/call ratio dipped to 1.57 on October 27 from 1.63 the day before, and from a high of 1.65 earlier in October. It still runs above its 20-day average of 1.53, but the z-score of 0.45 places it well inside normal range. The PCR pattern over the past month, rising from around 1.20 in late September to current levels, reflects a market that has been adding downside protection steadily rather than panicking into the event.

The debate between buyers and sellers centres on where AI-driven semiconductor test demand actually lands. The bull case points to Teradyne's exposure to AI compute testing, which analysts project could exceed 50% of semiconductor test revenue by 2027, alongside recovering HDD test orders. Analyst price targets sit at a mean of $445, roughly 37% above the current price, with Goldman Sachs at $465 and UBS at $500, both carrying Buy ratings. Baird moved to Neutral in August, but that note is now two months old. The bear case is more structural: smartphone end markets remain weak, robotics automation has been slower to scale than expected, and US-China trade friction creates ongoing uncertainty around a market where Teradyne has meaningful exposure. The PE multiple has compressed 21% over the past 30 days to around 29x, reflecting those concerns rather than dismissing them.

Insider activity in the 90-day window has been entirely on the sell side, with net disposals of roughly $5.9 million. The CEO sold 4,000 shares at $341.28 on October 15 under a pre-arranged 10b5-1 plan. Pre-planned trades are scheduled in advance and carry less signal than discretionary sales, but the absence of any open-market buying from the board heading into what would be a natural buying window is the detail the print will either validate or make irrelevant.

The report arrives at a moment when Teradyne's own borrowing market has quietly loosened and short sellers are trimming rather than pressing. What the print needs to resolve is whether the AI test revenue ramp is accelerating fast enough to justify a recovery toward the $445 consensus, or whether the margin profile after a 19% monthly decline is simply repricing the stock to reflect a longer, slower growth path.